William B. Walkup & Associates’s AbbVie ABBV Stock Holding History

William B. Walkup & Associates’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$6.62M	Sell	25,313 -79	-0.3%	-$20.3K	3.02%	7
2026 Q2	$6.39M	Sell	25,392 -745	-3%	-$160K	3.08%	8
2026 Q1	$5.48M	Buy	26,137 +532	+2%	+$118K	3.27%	7
2025 Q4	$5.85M	Sell	25,605 -560	-2%	-$128K	3.2%	7
2025 Q3	$6.06M	Sell	26,165 -7	-0%	-$1.42K	3.25%	7
2025 Q2	$4.86M	Buy	26,172 +35	+0.1%	+$6.5K	2.86%	8
2025 Q1	$5.48M	Buy	26,137 +1,126	+5%	+$219K	3.34%	7
2024 Q4	$4.44M	Sell	25,011 -159	-0.6%	-$29.2K	2.81%	9
2024 Q3	$4.97M	Sell	25,170 -107	-0.4%	-$20K	3.07%	8
2024 Q2	$4.34M	Buy	+25,277	New	+$4.19M	2.84%	8

Other funds holding ABBV

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return

Fisher Asset Management Camas, Washington $348B AUM 26.9% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

Mitsubishi UFJ Asset Management Tokyo, Japan $194B AUM 32.2% 1-Year Est. Return

Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return

LPL Financial San Diego, California $468B AUM 17.69% 1-Year Est. Return

PNC Financial Services Group Pittsburgh, Pennsylvania $191B AUM 30.51% 1-Year Est. Return

William B. Walkup & Associates's ABBV Position: Q3 2026 in Review

William B. Walkup & Associates reduced its AbbVie (ABBV) stake by 0.31% in Q3 2026, selling an estimated $20.3K and leaving 25,313 shares worth $6.62M. The position accounts for 3.02% of the portfolio, ranked #7.

William B. Walkup & Associates first reported a position in ABBV in Q2 2024 and has held it in 10 quarters since. 2,709 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.

William B. Walkup & Associates held 25,313 shares of AbbVie worth $6.62M as of Q3 2026.
William B. Walkup & Associates sold 79 AbbVie shares in Q3 2026, an estimated $20.3K.
AbbVie made up 3.02% of William B. Walkup & Associates's portfolio in Q3 2026, its #7 holding.
William B. Walkup & Associates first reported a position in AbbVie in Q2 2024 and has held it in 10 quarters since.
2,709 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.

Based on William B. Walkup & Associates's 13F filing for Q3 2026, filed 5 Nov 2026.